Hematology is a branch of medicine concerned with the study of blood, blood disease and the organs involved in forming blood.
LPI (LP Information)' newest research report, the “Hematology Therapies Industry Forecast” looks at past sales and reviews total world Hematology Therapies sales in 2022, providing a comprehensive analysis by region and market sector of projected Hematology Therapies sales for 2023 through 2029. With Hematology Therapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hematology Therapies industry.
This Insight Report provides a comprehensive analysis of the global Hematology Therapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hematology Therapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hematology Therapies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hematology Therapies and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hematology Therapies.
The global Hematology Therapies market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Hematology Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Hematology Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Hematology Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Hematology Therapies players cover Abbott Laboratories, Bio-Rad Laboratories, Roche, HORIBA, Beckman Coulter, Bayer, Sysmex, Ortho Clinical Diagnostic and Siemens Healthineers, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Hematology Therapies market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Hematology Instruments
Hematology Consumables
Segmentation by application
Diagnostic Laboratories
Hospitals and Clinics
Academic Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Bio-Rad Laboratories
Roche
HORIBA
Beckman Coulter
Bayer
Sysmex
Ortho Clinical Diagnostic
Siemens Healthineers
HemoCue
Boule Diagnostics
EKF Diagnostics
Drew Scientific
Mindray Medical

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Hematology Therapies Market Size 2018-2029 2.1.2 Hematology Therapies Market Size CAGR by Region 2018 VS 2022 VS 2029 2.2 Hematology Therapies Segment by Type 2.2.1 Hematology Instruments 2.2.2 Hematology Consumables 2.3 Hematology Therapies Market Size by Type 2.3.1 Hematology Therapies Market Size CAGR by Type (2018 VS 2022 VS 2029) 2.3.2 Global Hematology Therapies Market Size Market Share by Type (2018-2023) 2.4 Hematology Therapies Segment by Application 2.4.1 Diagnostic Laboratories 2.4.2 Hospitals and Clinics 2.4.3 Academic Institutes 2.4.4 Others 2.5 Hematology Therapies Market Size by Application 2.5.1 Hematology Therapies Market Size CAGR by Application (2018 VS 2022 VS 2029) 2.5.2 Global Hematology Therapies Market Size Market Share by Application (2018-2023) 3 Hematology Therapies Market Size by Player 3.1 Hematology Therapies Market Size Market Share by Players 3.1.1 Global Hematology Therapies Revenue by Players (2018-2023) 3.1.2 Global Hematology Therapies Revenue Market Share by Players (2018-2023) 3.2 Global Hematology Therapies Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Hematology Therapies by Regions 4.1 Hematology Therapies Market Size by Regions (2018-2023) 4.2 Americas Hematology Therapies Market Size Growth (2018-2023) 4.3 APAC Hematology Therapies Market Size Growth (2018-2023) 4.4 Europe Hematology Therapies Market Size Growth (2018-2023) 4.5 Middle East & Africa Hematology Therapies Market Size Growth (2018-2023) 5 Americas 5.1 Americas Hematology Therapies Market Size by Country (2018-2023) 5.2 Americas Hematology Therapies Market Size by Type (2018-2023) 5.3 Americas Hematology Therapies Market Size by Application (2018-2023) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Hematology Therapies Market Size by Region (2018-2023) 6.2 APAC Hematology Therapies Market Size by Type (2018-2023) 6.3 APAC Hematology Therapies Market Size by Application (2018-2023) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Hematology Therapies by Country (2018-2023) 7.2 Europe Hematology Therapies Market Size by Type (2018-2023) 7.3 Europe Hematology Therapies Market Size by Application (2018-2023) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Hematology Therapies by Region (2018-2023) 8.2 Middle East & Africa Hematology Therapies Market Size by Type (2018-2023) 8.3 Middle East & Africa Hematology Therapies Market Size by Application (2018-2023) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Hematology Therapies Market Forecast 10.1 Global Hematology Therapies Forecast by Regions (2024-2029) 10.1.1 Global Hematology Therapies Forecast by Regions (2024-2029) 10.1.2 Americas Hematology Therapies Forecast 10.1.3 APAC Hematology Therapies Forecast 10.1.4 Europe Hematology Therapies Forecast 10.1.5 Middle East & Africa Hematology Therapies Forecast 10.2 Americas Hematology Therapies Forecast by Country (2024-2029) 10.2.1 United States Hematology Therapies Market Forecast 10.2.2 Canada Hematology Therapies Market Forecast 10.2.3 Mexico Hematology Therapies Market Forecast 10.2.4 Brazil Hematology Therapies Market Forecast 10.3 APAC Hematology Therapies Forecast by Region (2024-2029) 10.3.1 China Hematology Therapies Market Forecast 10.3.2 Japan Hematology Therapies Market Forecast 10.3.3 Korea Hematology Therapies Market Forecast 10.3.4 Southeast Asia Hematology Therapies Market Forecast 10.3.5 India Hematology Therapies Market Forecast 10.3.6 Australia Hematology Therapies Market Forecast 10.4 Europe Hematology Therapies Forecast by Country (2024-2029) 10.4.1 Germany Hematology Therapies Market Forecast 10.4.2 France Hematology Therapies Market Forecast 10.4.3 UK Hematology Therapies Market Forecast 10.4.4 Italy Hematology Therapies Market Forecast 10.4.5 Russia Hematology Therapies Market Forecast 10.5 Middle East & Africa Hematology Therapies Forecast by Region (2024-2029) 10.5.1 Egypt Hematology Therapies Market Forecast 10.5.2 South Africa Hematology Therapies Market Forecast 10.5.3 Israel Hematology Therapies Market Forecast 10.5.4 Turkey Hematology Therapies Market Forecast 10.5.5 GCC Countries Hematology Therapies Market Forecast 10.6 Global Hematology Therapies Forecast by Type (2024-2029) 10.7 Global Hematology Therapies Forecast by Application (2024-2029) 11 Key Players Analysis 11.1 Abbott Laboratories 11.1.1 Abbott Laboratories Company Information 11.1.2 Abbott Laboratories Hematology Therapies Product Offered 11.1.3 Abbott Laboratories Hematology Therapies Revenue, Gross Margin and Market Share (2018-2023) 11.1.4 Abbott Laboratories Main Business Overview 11.1.5 Abbott Laboratories Latest Developments 11.2 Bio-Rad Laboratories 11.2.1 Bio-Rad Laboratories Company Information 11.2.2 Bio-Rad Laboratories Hematology Therapies Product Offered 11.2.3 Bio-Rad Laboratories Hematology Therapies Revenue, Gross Margin and Market Share (2018-2023) 11.2.4 Bio-Rad Laboratories Main Business Overview 11.2.5 Bio-Rad Laboratories Latest Developments 11.3 Roche 11.3.1 Roche Company Information 11.3.2 Roche Hematology Therapies Product Offered 11.3.3 Roche Hematology Therapies Revenue, Gross Margin and Market Share (2018-2023) 11.3.4 Roche Main Business Overview 11.3.5 Roche Latest Developments 11.4 HORIBA 11.4.1 HORIBA Company Information 11.4.2 HORIBA Hematology Therapies Product Offered 11.4.3 HORIBA Hematology Therapies Revenue, Gross Margin and Market Share (2018-2023) 11.4.4 HORIBA Main Business Overview 11.4.5 HORIBA Latest Developments 11.5 Beckman Coulter 11.5.1 Beckman Coulter Company Information 11.5.2 Beckman Coulter Hematology Therapies Product Offered 11.5.3 Beckman Coulter Hematology Therapies Revenue, Gross Margin and Market Share (2018-2023) 11.5.4 Beckman Coulter Main Business Overview 11.5.5 Beckman Coulter Latest Developments 11.6 Bayer 11.6.1 Bayer Company Information 11.6.2 Bayer Hematology Therapies Product Offered 11.6.3 Bayer Hematology Therapies Revenue, Gross Margin and Market Share (2018-2023) 11.6.4 Bayer Main Business Overview 11.6.5 Bayer Latest Developments 11.7 Sysmex 11.7.1 Sysmex Company Information 11.7.2 Sysmex Hematology Therapies Product Offered 11.7.3 Sysmex Hematology Therapies Revenue, Gross Margin and Market Share (2018-2023) 11.7.4 Sysmex Main Business Overview 11.7.5 Sysmex Latest Developments 11.8 Ortho Clinical Diagnostic 11.8.1 Ortho Clinical Diagnostic Company Information 11.8.2 Ortho Clinical Diagnostic Hematology Therapies Product Offered 11.8.3 Ortho Clinical Diagnostic Hematology Therapies Revenue, Gross Margin and Market Share (2018-2023) 11.8.4 Ortho Clinical Diagnostic Main Business Overview 11.8.5 Ortho Clinical Diagnostic Latest Developments 11.9 Siemens Healthineers 11.9.1 Siemens Healthineers Company Information 11.9.2 Siemens Healthineers Hematology Therapies Product Offered 11.9.3 Siemens Healthineers Hematology Therapies Revenue, Gross Margin and Market Share (2018-2023) 11.9.4 Siemens Healthineers Main Business Overview 11.9.5 Siemens Healthineers Latest Developments 11.10 HemoCue 11.10.1 HemoCue Company Information 11.10.2 HemoCue Hematology Therapies Product Offered 11.10.3 HemoCue Hematology Therapies Revenue, Gross Margin and Market Share (2018-2023) 11.10.4 HemoCue Main Business Overview 11.10.5 HemoCue Latest Developments 11.11 Boule Diagnostics 11.11.1 Boule Diagnostics Company Information 11.11.2 Boule Diagnostics Hematology Therapies Product Offered 11.11.3 Boule Diagnostics Hematology Therapies Revenue, Gross Margin and Market Share (2018-2023) 11.11.4 Boule Diagnostics Main Business Overview 11.11.5 Boule Diagnostics Latest Developments 11.12 EKF Diagnostics 11.12.1 EKF Diagnostics Company Information 11.12.2 EKF Diagnostics Hematology Therapies Product Offered 11.12.3 EKF Diagnostics Hematology Therapies Revenue, Gross Margin and Market Share (2018-2023) 11.12.4 EKF Diagnostics Main Business Overview 11.12.5 EKF Diagnostics Latest Developments 11.13 Drew Scientific 11.13.1 Drew Scientific Company Information 11.13.2 Drew Scientific Hematology Therapies Product Offered 11.13.3 Drew Scientific Hematology Therapies Revenue, Gross Margin and Market Share (2018-2023) 11.13.4 Drew Scientific Main Business Overview 11.13.5 Drew Scientific Latest Developments 11.14 Mindray Medical 11.14.1 Mindray Medical Company Information 11.14.2 Mindray Medical Hematology Therapies Product Offered 11.14.3 Mindray Medical Hematology Therapies Revenue, Gross Margin and Market Share (2018-2023) 11.14.4 Mindray Medical Main Business Overview 11.14.5 Mindray Medical Latest Developments 12 Research Findings and Conclusion